Mark Lowenthal - BioNeutral CEO
CEO
Mr. Mark Lowenthal is President, Chief Executive Officer, Director of BioNeutral Group, Inc. Mr. Lowenthal currently serves as a member of the Operation Executive Board of AUA Equity Partners, a position he has held since 2010. Prior to such, Mr. Lowenthal served as the President and Chief Executive Officer of European Soaps, LLC from 2008 to 2009. He also previously served as President of Revlon Europe, Asia and the Middle East from 1995 to 1999 where he was responsible for planning and implementing a restructuring of the companys business, including shifting from an individual country management approach to an integrated global approach. In addition, Mr. Lowenthal previously served as the President and General Manager of Almay, Inc. and as the VicePresident of Marketing of International Playtex, Inc since 2012.
| Age | 68 |
| Tenure | 12 years |
| Professional Marks | MBA |
| Phone | 973-577-8003 |
| Web | http://www.bioneutralgroup.com |
BioNeutral Management Efficiency
The company has return on total asset (ROA) of (21.6) % which means that it has lost $21.6 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (81.77) %, meaning that it created substantial loss on money invested by shareholders. BioNeutral's management efficiency ratios could be used to measure how well BioNeutral manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 2.14 M in liabilities with Debt to Equity (D/E) ratio of 68.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioNeutral Group has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioNeutral until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutral's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutral Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutral to invest in growth at high rates of return. When we think about BioNeutral's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 4 records | CEO Age | ||
| Michael McNamara | Flex | 59 | |
| Charles Prober | NETGEAR | 53 | |
| Michael Baur | ScanSource | 67 | |
| Liam Griffin | Skyworks Solutions | 57 | |
Management Performance
| Return On Equity | -81.77 | |||
| Return On Asset | -21.6 |
BioNeutral Group Leadership Team
Elected by the shareholders, the BioNeutral's board of directors comprises two types of representatives: BioNeutral inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioNeutral. The board's role is to monitor BioNeutral's management team and ensure that shareholders' interests are well served. BioNeutral's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioNeutral's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Tierno, Director | ||
| Andrew Kielbania, CTO, Chief Scientific Officer, Secretary and Director | ||
| Ben Hanafin, Independent Director | ||
| Mark Lowenthal, CEO and President Principal Financial Officer, Principal Accounting Officer and Director | ||
| Robert Machinist, Independent Director |
BioNeutral Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is BioNeutral a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -81.77 | |||
| Return On Asset | -21.6 | |||
| Current Valuation | 2.27 M | |||
| Shares Outstanding | 6.3 B | |||
| Shares Owned By Insiders | 9.99 % | |||
| Price To Book | 0.10 X | |||
| Price To Sales | 13.57 X | |||
| Revenue | 46.44 K | |||
| Gross Profit | 6.6 K | |||
| EBITDA | (2.44 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioNeutral in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioNeutral's short interest history, or implied volatility extrapolated from BioNeutral options trading.
Pair Trading with BioNeutral
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioNeutral position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNeutral will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in BioNeutral OTC Stock
If you are still planning to invest in BioNeutral Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioNeutral's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |